Beste apotheek van Nederland

Unnikrishnan A G, Rajaratnam S, Seshadri M S et al. The 'hook
effect' on serum prolactin estimation in a patient with
macroprolactinoma. Neurol India 2001;49(1):78-80.
Uygur M C, Arik A I, Altug U et al. Effects of the 5 alphareductase
inhibitor finasteride on serum levels of gonadal,
adrenal, and hypophyseal hormones and its clinical significance:
a prospective clinical study. Steroids 1998;63(4):208-213.
Valdevenito R, Melman A. Intracavernous self-injection
pharmacotherapy program: analysis of results and
complications. Int J Impot Res 1994;6(2):81-91.
van Basten J P, Van Driel M F, Hoekstra H J et al. Erectile
dysfunction with chemotherapy.[comment]. Lancet
2000;356(9224):169
van Basten J P, Van Driel M F, Hoekstra H J et al. Erectile
dysfunction with chemotherapy. Lancet 2000;356(9224):169
Van Ahlen H, Peskar B A, Sticht G et al. Pharmacokinetics of
vasoactive substances administered into the human corpus
cavernosum. Br J Urol 1994;151(5):1227-1230.
Van Moorselaar J. LUTS and Sexual Dysfunction: Implications
for Management of BPH. European Urology Supplements
2003;2(10):13-20.
Vatansever H S, Kayikcioglu O, Gumus B. Histopathologic
effect of chronic use of sildenafil citrate on the choroid & retina
in male rats. Indian J Med Res 2003;117(MAY):211-215.
Verit A, Oguz H. Ophthalmic aspects of erectile dysfunction
drugs [3]. Am J Ophthalmol 2006;141(3):598
Vick R N, Benevides M, Patel M et al. The efficacy, safety and
tolerability of intracavernous PNU-83757 for the treatment of
erectile dysfunction.. Br J Urol 2002;167(6):2618-2623.
Vickers M A, Wright E A. Erectile dysfunction in the patient
with diabetes mellitus. Am J Manag Care 2004;10(1
SUPPL.):S3-S11.
Vidal J, Curcoll L, Roig T et al. Intracavernous
pharmacotherapy for management of erectile dysfunction in
multiple sclerosis patients. Rev Neurol 1995;23(120):269-271.
Vinik A I, Maser R E, Mitchell B D et al. Diabetic autonomic
neuropathy. [Review] [192 refs]. Diabetes Care
2003;26(5):1553-1579.
Virag R, Floresco J, Richard C. Impairment of shear-stressmediated
vasodilation of cavernous arteries in erectile
dysfunction. Int J Impot Res 2004;16(1):39-42.
Vlachopoulos C, Hirata K, O'Rourke M F. Effect of sildenafil on
arterial stiffness and wave reflection. Vasc Med 2003;8(4):243­
248.
Vogt H J, Brandl P, Kockott G et al. Double-blind,
placebo-controlled safety and efficacy trial with
yohimbine hydrochloride in the treatment of
nonorganic erectile dysfunction. Int J Impot Res
1997;9(3):155-161.
Wagner G, Mulhall J. Pathophysiology and diagnosis
of male erectile dysfunction. BJU International ­
Supplement 2001;88(3):3-10.
Wagner G, Rabkin J, Rabkin R. Effects of testosterone
replacement therapy on sexual interest, function, and
behavior in HIV+ men. J Sex Res 1997;34(1):27-33.
Wagner Gorm, Kaplan Helen, Singer. The new
injection treatment for impotence: Medical and
psychological aspects. Refuat Hapeh Vehashinayim
1993;x, 210 pp. Philadelphia, PA, US210
Wald M, Seftel A D, Ross L S et al. Computational
models for detection of erectile dysfunction. Br J Urol
2005;173(1):167-170.
Waldbaum R S. The safety of PDE5 inhibitors in ED
treatment: Putting cardiovascular concerns to rest.
Cardiology Review 2005;22(9):23-24.
Wang Z L, Shao S X, Li B et al. Sildenafil versus
prostaglandin E1 in the management of erectile
dysfunction. Journal of Clinical Urology
2002;17(7):347-349.
Wang Z, Liu B C, Chen B et al. Randomized
controlled study on erectile dysfunction treated by
trazodone. Chinese Journal of Andrology
2002;16(3):236-238.
Ware J, Catesby Rose F, Vincent McBrayer et al. The
acute effects of nefazodone, trazodone and buspirone
on sleep and sleep-related penile tumescence in
normal subjects. Sleep: Journal of Sleep Research &
Sleep Medicine 1994;17(6):544-550.
Watanabe T, Chancellor M B, Rivas D A et al.
Epidemiology of current treatment for sexual
dysfunction in spinal cord injured men in the USA
model spinal cord injury centers. J Spinal Cord Med
1996;19(3):186-189.
Webb D J, Muirhead G J, Wulff M et al. Sildenafil
citrate potentiates the hypotensive effects of nitric
oxide donor drugs in male patients with stable angina.
J Am Coll Cardiol 2000;36(1):25-31.
Wegner H E H, Knispel H H, Meier T et al. Nitric
oxide donor, linsidomine chlorhydrate (SIN-1), in the
diagnosis and treatment of erectile dysfunction:
Critical appraisal and review of the literature.
International Urology & Nephrology 1995;27(5):621­
628.
D-210